CPA
SGHT icon

Capital Performance Advisors’s Sight Sciences SGHT Stock Holding History

Capital Performance Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-46
Closed -$290 – 2242
2024
Q3 		$290 Buy
+46
New +$310 ﹤0.01% 2470

Other funds holding SGHT

JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Capital Performance Advisors's SGHT Position: Q4 2024 in Review

Capital Performance Advisors sold out of Sight Sciences (SGHT) in Q4 2024, closing a stake of 46 shares — an estimated $290 sold.

Capital Performance Advisors first reported a position in SGHT in Q3 2024 and held it in 1 quarter. The position peaked at $290 in Q3 2024. 83 funds tracked by Wall St. Rank hold SGHT as of Q4 2024.

  • Capital Performance Advisors reported no remaining Sight Sciences position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 46 Sight Sciences shares in Q4 2024, an estimated $290.
  • Capital Performance Advisors first reported a position in Sight Sciences in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Sight Sciences position peaked at $290 in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.